Oncology and Cancer Biomarkers

CirQuest Labs partners with pharmaceutical companies in the planning, design, and execution of targeted companion diagnostics platforms for drug therapies. Our established track record of taking biomarker discovery from conception through clinical validation, along with our basic science and translational experience in cancer biology, makes CirQuest an ideal collaborator from proof-of-concept through Phase IV clinical testing. We also assist in identifying suitable patient populations for study enrollment, which may improve drug efficacy and therefore increase the likelihood of gaining regulatory approval.

To discuss how we can assist your organization with these support services, please contact us today.

CirQuest’s cancer biomarker tests include: